细胞毒性与非细胞毒性抗肿瘤药固体制剂生产区设计差异性探讨  

Discussion of Difference between Designs of Cytotoxic and Non-cytotoxic Oncology OSD Manufacturing Facilities

作　　者：温艳华 

机构地区：[1]浙江海正药业股份有限公司,台州318000

出　　处：《化工与医药工程》2016年第2期32-34,共3页Chemical and Pharmaceutical Engineering

摘　　要：抗肿瘤药物分为细胞毒性药物和非细胞毒性药物,其生产厂房的设计要求差异性很大,探讨抗肿瘤药物制剂生产厂房设计的核心环节,为制药企业生产厂房设计提供参考。Oncology drugs are divided into cytotoxic drugs and non-cytotoxic drugs, and the requirements in the design of facilities for these two kinds of drugs are quite different. In this paper, the key in the design of facility for manufacturing oncology OSD was discussed, which may be used as reference in the design of facilities in pharmaceutical industry.

关 键 词：细胞毒性 非细胞毒性 制剂生产厂房 设计差异性 

分 类 号：TQ460.6[化学工程—制药化工]